Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)
Stereotaxis, Inc. designs, manufactures, and markets robotic magnetic navigation (MRI) systems for use in the hospital's interventional operating room to improve the treatment of arrhythmias and coronary artery disease in the United States and internationally. The company is headquartered in St. Louis, Missouri.
52W High
$3.05
52W Low
$1.54
MA Status:
50D: Above
200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.61
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-10.06
EV/Revenue (<3 favorable)
8.43
P/S (TTM) (<3 favorable)
8.30
P/B (<3 favorable)
181.38
Ownership
BalancedSource: Overview
Insiders (1–5% typical)
30.00%
Institutions (25–75% balanced)
46.30%
Shares Outstanding
91,068,000
Float
63,519,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
31,806,000
Gross Profit (TTM)
15,958,000
EPS (TTM)
-0.29
Profit Margin (>10% good)
-0.73%
Operating Margin (TTM) (higher better)
-0.45%
ROE (TTM) (>15% strong)
-1.99%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.95
Momentum
Bearish momentumValue
0.0982
Previous
0.1040
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025